Page last updated: 2024-12-07

bn 52211

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

BN 52211: a newly synthesized aza alkyl lysophosplipid of MW 536; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID131968
CHEMBL ID2001852
SCHEMBL ID9614165
MeSH IDM0196439

Synonyms (11)

Synonym
3,5-dioxa-9-aza-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-n,n,n,9-tetramethyl-, hydroxide, inner salt, 4-oxide
bn 52211
nsc-643828
9-aza-3, 4-hydroxy- 7-methoxy-9,n,n,n-tetramethyl-, inner salt,4-oxide
choline, 2-methoxy- 3-[methyl(octadecyl)amino]propyl hydrogen phosphate, inner salt
nsc643828
136533-74-9
CHEMBL2001852
SCHEMBL9614165
DTXSID90929458
2-methoxy-3-[methyl(octadecyl)amino]propyl 2-(trimethylazaniumyl)ethyl phosphate

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]